Compare PTGX & NE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | NE |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.7B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | NE |
|---|---|---|
| Price | $89.29 | $32.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $86.44 | $32.50 |
| AVG Volume (30 Days) | 898.7K | ★ 1.5M |
| Earning Date | 11-06-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 6.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 1.40 |
| Revenue | $209,217,000.00 | ★ $3,283,999,000.00 |
| Revenue This Year | N/A | $14.57 |
| Revenue Next Year | $296.47 | N/A |
| P/E Ratio | $124.48 | ★ $23.39 |
| Revenue Growth | N/A | ★ 24.12 |
| 52 Week Low | $33.70 | $17.40 |
| 52 Week High | $93.25 | $35.06 |
| Indicator | PTGX | NE |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 63.97 |
| Support Level | $83.52 | $30.26 |
| Resistance Level | $90.85 | $33.66 |
| Average True Range (ATR) | 2.63 | 1.24 |
| MACD | -0.33 | 0.27 |
| Stochastic Oscillator | 83.62 | 82.65 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.